Skip to content

Evaluation of the Role of Latent Toxoplasmosis in Female Patients With Active Acne Vulgaris

Evaluation of the Role of Latent Toxoplasmosis in Female Patients With Active Acne Vulgaris

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05783778
Enrollment
200
Registered
2023-03-24
Start date
2023-06-01
Completion date
2024-12-01
Last updated
2023-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris, Toxoplasmosis

Brief summary

Acne vulgaris is one if the most common chronic inflammatory skin disorders.Acne is characterized by forming of inflammatory and non inflammatory lesions mainly on the Face,neck,arms, upper trunk and back

Detailed description

One of the hidden hormonal imbalance is Toxoplasma infection.Toxoplasmosis is a zoonotic infection the definite host is feline whereas human and other warm blooded animals are intermediate host . Endocrine alterations occuring during toxoplasmosis can be a hidden cause of acne vulgaris

Interventions

DIAGNOSTIC_TESTFree testosterone levels and toxoplasma igG

Free testosterone levels and toxoplasma igG in serum by ELISA

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

\- Female patients with active acne vulgaris

Exclusion criteria

* Patients with history of hormonal treatment Patients received anti toxoplasma therapy Patients with dermatological diseases caused by hormonal disturbances Pregnant and lactating patients

Design outcomes

Primary

MeasureTime frameDescription
Measuring Toxoplasma igG and free testosterone in acne vulgaris patients and controlsOne monthDetect if the toxoplasma latent infection can be associated with disease severity and hormonal disturbances in acne vulgaris female patients

Contacts

Primary ContactWafaa Mohamed Abdel Mageed
Wafaaderm78@yahoo.com01008813349
Backup ContactRasha Ismail Mohamed
r.alkady21@gmail.com01006592879

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026